TY - JOUR
AU - Cheetham, Nathan J.
AU - Kibble, Milla
AU - Wong, Andrew
AU - Silverwood, Richard J.
AU - Knuppel, Anika
AU - Williams, Dylan M.
AU - Hamilton, Olivia K.L.
AU - Lee, Paul H.
AU - Bridger Staatz, Charis
AU - Di Gessa, Giorgio
AU - Zhu, Jingmin
AU - Katikireddi, Srinivasa Vittal
AU - Ploubidis, George B.
AU - Thompson, Ellen J.
AU - Bowyer, Ruth C.E.
AU - Zhang, Xinyuan
AU - Abbasian, Golboo
AU - Garcia, Maria Paz
AU - Hart, Deborah
AU - Seow, Jeffrey
AU - Graham, Carl
AU - Kouphou, Neophytos
AU - Acors, Sam
AU - Malim, Michael H.
AU - Mitchell, Ruth E.
AU - Northstone, Kate
AU - Major-Smith, Daniel
AU - Matthews, Sarah
AU - Breeze, Thomas
AU - Crawford, Michael
AU - Molloy, Lynn
AU - Kwong, Alex S.F.
AU - Doores, Katie J.
AU - Chaturvedi, Nishi
AU - Duncan, Emma L.
AU - Timpson, Nicholas J.
AU - Steves, Claire J.
PY - 2023
DA - January
TI - Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors
JO - eLife
DO - https://doi.org/10.7554/eLife.80428
AB - Background:SARS-CoV-2 antibody levels can be used to assess humoral immune responses following SARS-CoV-2 infection or vaccination, and may predict risk of future infection. Higher levels of SARS-CoV-2 anti-Spike antibodies are known to be associated with increased protection against future SARS-CoV-2 infection. However, variation in antibody levels and risk factors for lower antibody levels following each round of SARS-CoV-2 vaccination have not been explored across a wide range of socio-demographic, SARS-CoV-2 infection and vaccination, and health factors within population-based cohorts.
PB - eLife Sciences Publications
UR - https://eprints.gla.ac.uk/289011/
KW - Coronavirus (COVID-19)
ER